Peter J. Mazzone, MD, MPH, FCCP

Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma. By Lawrence D. Sher, MD, et al.

Carriage and Transmission of Macrolide Resistance Genes in Patients With Chronic Respiratory Conditions and Their Close Contacts. By Yiming Wang, MSc, et al.

An Evaluation of Factors That Influence Referral to Pulmonary Rehabilitation Programs Among People With COPD. By Sarah Hug, BSc, et al.

Prevalence and Outcomes of Previously Healthy Adults Among Patients Hospitalized With Community-Onset Sepsis. By Mohammad Alrawashdeh, PhD, MSN, et al.

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study. By Franck F. Rahaghi, MD, et al.

Race- and Ethnicity-Based Spirometry Reference Equations: Are They Accurate for Genetically Admixed Children? By Jonathan Witonsky, MD, et al.

No VTE Recurrence After 1-Year Follow Up of Hospitalized Patients With COVID-19 and a VTE Event: A Prospective Study. By Maxime Delrue, MD, PhD, et al.
 

Patient Perspectives on Longitudinal Adherence to Lung Cancer Screening. By Anna Holman, BS, et al.

Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma. By Lawrence D. Sher, MD, et al.

Carriage and Transmission of Macrolide Resistance Genes in Patients With Chronic Respiratory Conditions and Their Close Contacts. By Yiming Wang, MSc, et al.

An Evaluation of Factors That Influence Referral to Pulmonary Rehabilitation Programs Among People With COPD. By Sarah Hug, BSc, et al.

Prevalence and Outcomes of Previously Healthy Adults Among Patients Hospitalized With Community-Onset Sepsis. By Mohammad Alrawashdeh, PhD, MSN, et al.

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study. By Franck F. Rahaghi, MD, et al.

Race- and Ethnicity-Based Spirometry Reference Equations: Are They Accurate for Genetically Admixed Children? By Jonathan Witonsky, MD, et al.

No VTE Recurrence After 1-Year Follow Up of Hospitalized Patients With COVID-19 and a VTE Event: A Prospective Study. By Maxime Delrue, MD, PhD, et al.
 

Patient Perspectives on Longitudinal Adherence to Lung Cancer Screening. By Anna Holman, BS, et al.

Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma. By Lawrence D. Sher, MD, et al.

Carriage and Transmission of Macrolide Resistance Genes in Patients With Chronic Respiratory Conditions and Their Close Contacts. By Yiming Wang, MSc, et al.

An Evaluation of Factors That Influence Referral to Pulmonary Rehabilitation Programs Among People With COPD. By Sarah Hug, BSc, et al.

Prevalence and Outcomes of Previously Healthy Adults Among Patients Hospitalized With Community-Onset Sepsis. By Mohammad Alrawashdeh, PhD, MSN, et al.

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study. By Franck F. Rahaghi, MD, et al.

Race- and Ethnicity-Based Spirometry Reference Equations: Are They Accurate for Genetically Admixed Children? By Jonathan Witonsky, MD, et al.

No VTE Recurrence After 1-Year Follow Up of Hospitalized Patients With COVID-19 and a VTE Event: A Prospective Study. By Maxime Delrue, MD, PhD, et al.
 

Patient Perspectives on Longitudinal Adherence to Lung Cancer Screening. By Anna Holman, BS, et al.

The Relationship Between Insurance Status and The Affordable Care Act on Asthma Outcomes Among Low-Income Us Adults. By Dr. Rajat Suri et al.

Characteristics and Outcomes of Intensive Care Unit Patients With Respiratory Syncytial Virus Compared to Those With Influenza Infection: A Multicentre Matched Cohort Study. By Dr. Julien Coussement et al

“Can Do, Do Do” Quadrants and 6-Year All-Cause Mortality in Patients with COPD. By Dr. Anouk W. Vaes et al.

Trends in Geriatric Conditions Among Older Adults Admitted to US ICUs Between 1998 and 2015. By Dr. Julien Cobert et al.

Setting and Titrating Positive End-Expiratory Pressure. By Dr. Scott J. Millington et al.

COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition. By Dr. Bruno Guedes Baldi et al.

Perceptions of Life Support and Advance Care Planning During the COVID-19 Pandemic: A Global Study of Twitter Users. By Vishal R. Patel et al.

Framework for Integrating Equity Into Machine Learning Models: A Case Study. By Dr. Juan C. Rojas et al.

Comparison of Guidelines for Evaluation of Suspected Pulmonary Embolism in Pregnancy: A Cost-Effectiveness Analysis. By John Austin McCandlish et al.

Relationship Between CPAP Termination and All-Cause Mortality: A French Nationwide Database Analysis. By Dr. Jean-Louis Pépin et al.

Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Non-small Cell Lung Cancer and Preexisting Interstitial Lung Diseases: A Systematic Review and Meta-Analysis. By Dr. Meng Zhang, et al.

The Impact of Persistent Smoking After Surgery on Long-Term Outcomes After Stage I Non–Small Cell Lung Cancer Resection. By Dr. Brendan T. Heiden et al.

The Relationship Between Insurance Status and The Affordable Care Act on Asthma Outcomes Among Low-Income Us Adults. By Dr. Rajat Suri et al.

Characteristics and Outcomes of Intensive Care Unit Patients With Respiratory Syncytial Virus Compared to Those With Influenza Infection: A Multicentre Matched Cohort Study. By Dr. Julien Coussement et al

“Can Do, Do Do” Quadrants and 6-Year All-Cause Mortality in Patients with COPD. By Dr. Anouk W. Vaes et al.

Trends in Geriatric Conditions Among Older Adults Admitted to US ICUs Between 1998 and 2015. By Dr. Julien Cobert et al.

Setting and Titrating Positive End-Expiratory Pressure. By Dr. Scott J. Millington et al.

COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition. By Dr. Bruno Guedes Baldi et al.

Perceptions of Life Support and Advance Care Planning During the COVID-19 Pandemic: A Global Study of Twitter Users. By Vishal R. Patel et al.

Framework for Integrating Equity Into Machine Learning Models: A Case Study. By Dr. Juan C. Rojas et al.

Comparison of Guidelines for Evaluation of Suspected Pulmonary Embolism in Pregnancy: A Cost-Effectiveness Analysis. By John Austin McCandlish et al.

Relationship Between CPAP Termination and All-Cause Mortality: A French Nationwide Database Analysis. By Dr. Jean-Louis Pépin et al.

Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Non-small Cell Lung Cancer and Preexisting Interstitial Lung Diseases: A Systematic Review and Meta-Analysis. By Dr. Meng Zhang, et al.

The Impact of Persistent Smoking After Surgery on Long-Term Outcomes After Stage I Non–Small Cell Lung Cancer Resection. By Dr. Brendan T. Heiden et al.

The Relationship Between Insurance Status and The Affordable Care Act on Asthma Outcomes Among Low-Income Us Adults. By Dr. Rajat Suri et al.

Characteristics and Outcomes of Intensive Care Unit Patients With Respiratory Syncytial Virus Compared to Those With Influenza Infection: A Multicentre Matched Cohort Study. By Dr. Julien Coussement et al

“Can Do, Do Do” Quadrants and 6-Year All-Cause Mortality in Patients with COPD. By Dr. Anouk W. Vaes et al.

Trends in Geriatric Conditions Among Older Adults Admitted to US ICUs Between 1998 and 2015. By Dr. Julien Cobert et al.

Setting and Titrating Positive End-Expiratory Pressure. By Dr. Scott J. Millington et al.

COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition. By Dr. Bruno Guedes Baldi et al.

Perceptions of Life Support and Advance Care Planning During the COVID-19 Pandemic: A Global Study of Twitter Users. By Vishal R. Patel et al.

Framework for Integrating Equity Into Machine Learning Models: A Case Study. By Dr. Juan C. Rojas et al.

Comparison of Guidelines for Evaluation of Suspected Pulmonary Embolism in Pregnancy: A Cost-Effectiveness Analysis. By John Austin McCandlish et al.

Relationship Between CPAP Termination and All-Cause Mortality: A French Nationwide Database Analysis. By Dr. Jean-Louis Pépin et al.

Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Non-small Cell Lung Cancer and Preexisting Interstitial Lung Diseases: A Systematic Review and Meta-Analysis. By Dr. Meng Zhang, et al.

The Impact of Persistent Smoking After Surgery on Long-Term Outcomes After Stage I Non–Small Cell Lung Cancer Resection. By Dr. Brendan T. Heiden et al.

Genetic Associations and Architecture of Asthma-COPD Overlap. By Catherine John, et al.

Emerging Nonpulmonary Complications for Adults With Cystic Fibrosis. By Dr. Melanie Chin, et al.

Aspirin as a Treatment for ARDS: A Randomized, Placebo-Controlled Clinical Trial. By Dr. Philip Toner, et al.

PICU in the MICU: How Adult ICUs Can Support Pediatric Care in Public Health Emergencies. By Dr. Mary A. King, et al.

Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung Disease. By Dr. Alessia Comes, et al.

Off-Label Use and Inappropriate Dosing of Direct Oral Anticoagulants in Cardiopulmonary Disease. By Dr. Ayman A. Hussein, et al.

Genetic Associations and Architecture of Asthma-COPD Overlap. By Catherine John, et al.

Emerging Nonpulmonary Complications for Adults With Cystic Fibrosis. By Dr. Melanie Chin, et al.

Aspirin as a Treatment for ARDS: A Randomized, Placebo-Controlled Clinical Trial. By Dr. Philip Toner, et al.

PICU in the MICU: How Adult ICUs Can Support Pediatric Care in Public Health Emergencies. By Dr. Mary A. King, et al.

Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung Disease. By Dr. Alessia Comes, et al.

Off-Label Use and Inappropriate Dosing of Direct Oral Anticoagulants in Cardiopulmonary Disease. By Dr. Ayman A. Hussein, et al.

Genetic Associations and Architecture of Asthma-COPD Overlap. By Catherine John, et al.

Emerging Nonpulmonary Complications for Adults With Cystic Fibrosis. By Dr. Melanie Chin, et al.

Aspirin as a Treatment for ARDS: A Randomized, Placebo-Controlled Clinical Trial. By Dr. Philip Toner, et al.

PICU in the MICU: How Adult ICUs Can Support Pediatric Care in Public Health Emergencies. By Dr. Mary A. King, et al.

Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung Disease. By Dr. Alessia Comes, et al.

Off-Label Use and Inappropriate Dosing of Direct Oral Anticoagulants in Cardiopulmonary Disease. By Dr. Ayman A. Hussein, et al.

Bronchial thermoplasty in severe asthmatics at 5 years: The PAS2 study. By Dr. G. Chupp, et al.

Significant spirometric transitions and preserved ratio-impaired spirometry (PRISm) among ever-smokers. By Dr. E. Wan, et al.

Addressing advance care planning in patients with COPD. By Dr. E. Rose, et al.

The cost of ARDS: A systematic review. By Dr. P. Boucher, et al.

Acute management of high- and intermediate-risk pulmonary embolism in children: A review. By Dr. C. Ross, et al.

Surgical outcomes for early-stage non-small cell lung cancer at facilities with stereotactic body radiation therapy programs. By Dr. Y. Syed, et al.

Bronchial thermoplasty in severe asthmatics at 5 years: The PAS2 study. By Dr. G. Chupp, et al.

Significant spirometric transitions and preserved ratio-impaired spirometry (PRISm) among ever-smokers. By Dr. E. Wan, et al.

Addressing advance care planning in patients with COPD. By Dr. E. Rose, et al.

The cost of ARDS: A systematic review. By Dr. P. Boucher, et al.

Acute management of high- and intermediate-risk pulmonary embolism in children: A review. By Dr. C. Ross, et al.

Surgical outcomes for early-stage non-small cell lung cancer at facilities with stereotactic body radiation therapy programs. By Dr. Y. Syed, et al.

Bronchial thermoplasty in severe asthmatics at 5 years: The PAS2 study. By Dr. G. Chupp, et al.

Significant spirometric transitions and preserved ratio-impaired spirometry (PRISm) among ever-smokers. By Dr. E. Wan, et al.

Addressing advance care planning in patients with COPD. By Dr. E. Rose, et al.

The cost of ARDS: A systematic review. By Dr. P. Boucher, et al.

Acute management of high- and intermediate-risk pulmonary embolism in children: A review. By Dr. C. Ross, et al.

Surgical outcomes for early-stage non-small cell lung cancer at facilities with stereotactic body radiation therapy programs. By Dr. Y. Syed, et al.

Revisiting mild asthma: current knowledge and future needs. By Dr. A. Mohan, et al.



Treatment of Mycobacterium abscessus pulmonary disease. By Dr. D. Griffith, et al.



The utility of the rapid shallow breathing index in predicting successful extubation: A systematic review and meta-analysis. By Dr. K. Burns, et al.



National temporal trends in hospitalization and inpatient mortality in patients with pulmonary sarcoidosis in the United States between 2007 – 2018. By Dr. N. Obi Ogugua, et al.



How I Do It: Considering lung transplantation for patients with COVID-19. By Dr. S. Nathan.



Addressing race in pulmonary function testing by aligning intent and evidence with practice and perception. By Dr. N. Bhakta, et al.

Revisiting mild asthma: current knowledge and future needs. By Dr. A. Mohan, et al.



Treatment of Mycobacterium abscessus pulmonary disease. By Dr. D. Griffith, et al.



The utility of the rapid shallow breathing index in predicting successful extubation: A systematic review and meta-analysis. By Dr. K. Burns, et al.



National temporal trends in hospitalization and inpatient mortality in patients with pulmonary sarcoidosis in the United States between 2007 – 2018. By Dr. N. Obi Ogugua, et al.



How I Do It: Considering lung transplantation for patients with COVID-19. By Dr. S. Nathan.



Addressing race in pulmonary function testing by aligning intent and evidence with practice and perception. By Dr. N. Bhakta, et al.

Revisiting mild asthma: current knowledge and future needs. By Dr. A. Mohan, et al.



Treatment of Mycobacterium abscessus pulmonary disease. By Dr. D. Griffith, et al.



The utility of the rapid shallow breathing index in predicting successful extubation: A systematic review and meta-analysis. By Dr. K. Burns, et al.



National temporal trends in hospitalization and inpatient mortality in patients with pulmonary sarcoidosis in the United States between 2007 – 2018. By Dr. N. Obi Ogugua, et al.



How I Do It: Considering lung transplantation for patients with COVID-19. By Dr. S. Nathan.



Addressing race in pulmonary function testing by aligning intent and evidence with practice and perception. By Dr. N. Bhakta, et al.

Fertility and pregnancy in cystic fibrosis By Dr. M. Shteinberg, et al.Changes in purchases for intensive care medicines during the COVID-19 pandemic: A global time series study By Dr. K. Kim, et al.The impact of obesity in critical illness By Drs. M.R. Anderson and M. Shashaty



Strategies to improve bedside clinical skills teaching By Drs. B. Garibaldi and S.W. RussellAntithrombotic therapy for VTE Disease: Second update of the CHEST guideline and expert panel report – executive summary By Dr. S.M. Stevens, et al.

Fertility and pregnancy in cystic fibrosis By Dr. M. Shteinberg, et al.Changes in purchases for intensive care medicines during the COVID-19 pandemic: A global time series study By Dr. K. Kim, et al.The impact of obesity in critical illness By Drs. M.R. Anderson and M. Shashaty



Strategies to improve bedside clinical skills teaching By Drs. B. Garibaldi and S.W. RussellAntithrombotic therapy for VTE Disease: Second update of the CHEST guideline and expert panel report – executive summary By Dr. S.M. Stevens, et al.

Fertility and pregnancy in cystic fibrosis By Dr. M. Shteinberg, et al.Changes in purchases for intensive care medicines during the COVID-19 pandemic: A global time series study By Dr. K. Kim, et al.The impact of obesity in critical illness By Drs. M.R. Anderson and M. Shashaty



Strategies to improve bedside clinical skills teaching By Drs. B. Garibaldi and S.W. RussellAntithrombotic therapy for VTE Disease: Second update of the CHEST guideline and expert panel report – executive summary By Dr. S.M. Stevens, et al.

How I do it: Transitioning asthma care from adolescents to adults: Severe Asthma Series. By Dr. A. Nanzer.



Outpatient management of patients with COVID-19: Multicenter prospective validation of the HOME-CoV Rule to safely discharge patients. By Dr. D. Douillet, et al.



Emphysema progression and lung function decline among angiotensin converting enzyme inhibitors (ACEi) and angiotensin-receptor blockade (ARB) users in the COPDGene Cohort. By Dr. V. Tejwani, et al.



Sarcoidosis: An occupational disease? By Dr. C.L. Oliver, et al.



Pulmonary thrombosis and thromboembolism in COVID-19. By Dr. H. Poor.



How I do it: Mediastinal staging for lung cancer. By Dr. F. Farjah, et al.




 

How I do it: Transitioning asthma care from adolescents to adults: Severe Asthma Series. By Dr. A. Nanzer.



Outpatient management of patients with COVID-19: Multicenter prospective validation of the HOME-CoV Rule to safely discharge patients. By Dr. D. Douillet, et al.



Emphysema progression and lung function decline among angiotensin converting enzyme inhibitors (ACEi) and angiotensin-receptor blockade (ARB) users in the COPDGene Cohort. By Dr. V. Tejwani, et al.



Sarcoidosis: An occupational disease? By Dr. C.L. Oliver, et al.



Pulmonary thrombosis and thromboembolism in COVID-19. By Dr. H. Poor.



How I do it: Mediastinal staging for lung cancer. By Dr. F. Farjah, et al.




 

How I do it: Transitioning asthma care from adolescents to adults: Severe Asthma Series. By Dr. A. Nanzer.



Outpatient management of patients with COVID-19: Multicenter prospective validation of the HOME-CoV Rule to safely discharge patients. By Dr. D. Douillet, et al.



Emphysema progression and lung function decline among angiotensin converting enzyme inhibitors (ACEi) and angiotensin-receptor blockade (ARB) users in the COPDGene Cohort. By Dr. V. Tejwani, et al.



Sarcoidosis: An occupational disease? By Dr. C.L. Oliver, et al.



Pulmonary thrombosis and thromboembolism in COVID-19. By Dr. H. Poor.



How I do it: Mediastinal staging for lung cancer. By Dr. F. Farjah, et al.




 

Peak inspiratory flow as a predictive therapeutic biomarker in COPD. By Drs. D. Mahler and D. Halpin.Family presence for critically ill patients during a pandemic. By Drs. J. Hart and S. Taylor.



Executive summary: diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report. By Dr. L. Fernandez Perez et al.



The usefulness of chest CT imaging in patients with suspected or diagnosed COVID-19: A review of literature. By Dr. S. Machnicki et al.



Oxygen therapy in sleep-disordered breathing. By Dr. S. Zeineddine et al.

Peak inspiratory flow as a predictive therapeutic biomarker in COPD. By Drs. D. Mahler and D. Halpin.Family presence for critically ill patients during a pandemic. By Drs. J. Hart and S. Taylor.



Executive summary: diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report. By Dr. L. Fernandez Perez et al.



The usefulness of chest CT imaging in patients with suspected or diagnosed COVID-19: A review of literature. By Dr. S. Machnicki et al.



Oxygen therapy in sleep-disordered breathing. By Dr. S. Zeineddine et al.

Peak inspiratory flow as a predictive therapeutic biomarker in COPD. By Drs. D. Mahler and D. Halpin.Family presence for critically ill patients during a pandemic. By Drs. J. Hart and S. Taylor.



Executive summary: diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report. By Dr. L. Fernandez Perez et al.



The usefulness of chest CT imaging in patients with suspected or diagnosed COVID-19: A review of literature. By Dr. S. Machnicki et al.



Oxygen therapy in sleep-disordered breathing. By Dr. S. Zeineddine et al.

Hormone replacement therapy and development of new asthma. By Dr. E. Hansen et al.



Sex and gender omic biomarkers in men and women with COPD: Considerations for precision medicine. By Dr. D. Demeo.



Pulmonary function and radiological features in survivors of critical covid-19: A 3-month prospective cohort. By Dr. F. Barbe et al.



Characteristics and prevalence of domestic and occupational inhalational exposures across interstitial lung diseases. By Dr. C. Lee et al.



Identification and remediation of environmental exposures in patients with interstitial lung disease: Evidence review and practical considerations. By Dr. M. Salisbury et al.



How we do it: Creating an organizational culture for the chest physician. By Dr. J. Stoller et al..



Proposed quality metrics for lung cancer screening programs: A national lung cancer roundtable project. By Dr. P. Mazzone et al.

Hormone replacement therapy and development of new asthma. By Dr. E. Hansen et al.



Sex and gender omic biomarkers in men and women with COPD: Considerations for precision medicine. By Dr. D. Demeo.



Pulmonary function and radiological features in survivors of critical covid-19: A 3-month prospective cohort. By Dr. F. Barbe et al.



Characteristics and prevalence of domestic and occupational inhalational exposures across interstitial lung diseases. By Dr. C. Lee et al.



Identification and remediation of environmental exposures in patients with interstitial lung disease: Evidence review and practical considerations. By Dr. M. Salisbury et al.



How we do it: Creating an organizational culture for the chest physician. By Dr. J. Stoller et al..



Proposed quality metrics for lung cancer screening programs: A national lung cancer roundtable project. By Dr. P. Mazzone et al.

Hormone replacement therapy and development of new asthma. By Dr. E. Hansen et al.



Sex and gender omic biomarkers in men and women with COPD: Considerations for precision medicine. By Dr. D. Demeo.



Pulmonary function and radiological features in survivors of critical covid-19: A 3-month prospective cohort. By Dr. F. Barbe et al.



Characteristics and prevalence of domestic and occupational inhalational exposures across interstitial lung diseases. By Dr. C. Lee et al.



Identification and remediation of environmental exposures in patients with interstitial lung disease: Evidence review and practical considerations. By Dr. M. Salisbury et al.



How we do it: Creating an organizational culture for the chest physician. By Dr. J. Stoller et al..



Proposed quality metrics for lung cancer screening programs: A national lung cancer roundtable project. By Dr. P. Mazzone et al.

1. POINT: Is It Ethically Permissible to Unilaterally Withdraw Life-Sustaining Treatments During Crisis Standards of Care? YesBy Dr. J. Bishop and Dr. J. Eberl



2. COUNTERPOINT: Is It Ethically Permissible to Unilaterally Withdraw Life-Sustaining Treatments for Reallocation During Crisis Standards of Care? NoBy Dr. D. Sulmasy and Dr. F. Maldonado



3. National Trends and Disparities in Health-Care Access and Coverage Among Adults With Asthma and COPD: 1997-2018By Dr. A. Gaffney, et al.



4. Geographic Variation in Racial Disparities in Mortality From Influenza and Pneumonia in the United States in the Pre-Coronavirus Disease 2019 EraBy Dr. S. Donaldson, et al.



5. Palliative Care Needs and Integration of Palliative Care Support in COPD: A Qualitative StudyBy Dr. F. Yu, et al.



6. How I Do It: Building Teams in Health CareBy. Dr. J. Stoller

1. POINT: Is It Ethically Permissible to Unilaterally Withdraw Life-Sustaining Treatments During Crisis Standards of Care? YesBy Dr. J. Bishop and Dr. J. Eberl



2. COUNTERPOINT: Is It Ethically Permissible to Unilaterally Withdraw Life-Sustaining Treatments for Reallocation During Crisis Standards of Care? NoBy Dr. D. Sulmasy and Dr. F. Maldonado



3. National Trends and Disparities in Health-Care Access and Coverage Among Adults With Asthma and COPD: 1997-2018By Dr. A. Gaffney, et al.



4. Geographic Variation in Racial Disparities in Mortality From Influenza and Pneumonia in the United States in the Pre-Coronavirus Disease 2019 EraBy Dr. S. Donaldson, et al.



5. Palliative Care Needs and Integration of Palliative Care Support in COPD: A Qualitative StudyBy Dr. F. Yu, et al.



6. How I Do It: Building Teams in Health CareBy. Dr. J. Stoller

1. POINT: Is It Ethically Permissible to Unilaterally Withdraw Life-Sustaining Treatments During Crisis Standards of Care? YesBy Dr. J. Bishop and Dr. J. Eberl



2. COUNTERPOINT: Is It Ethically Permissible to Unilaterally Withdraw Life-Sustaining Treatments for Reallocation During Crisis Standards of Care? NoBy Dr. D. Sulmasy and Dr. F. Maldonado



3. National Trends and Disparities in Health-Care Access and Coverage Among Adults With Asthma and COPD: 1997-2018By Dr. A. Gaffney, et al.



4. Geographic Variation in Racial Disparities in Mortality From Influenza and Pneumonia in the United States in the Pre-Coronavirus Disease 2019 EraBy Dr. S. Donaldson, et al.



5. Palliative Care Needs and Integration of Palliative Care Support in COPD: A Qualitative StudyBy Dr. F. Yu, et al.



6. How I Do It: Building Teams in Health CareBy. Dr. J. Stoller